News – Page 37 – Alligator Bioscience

2015-08-122022-09-20

Alligator Bioscience Announces Collaboration with Johnson & Johnson Innovation for the CD40 Agonistic Immuno-Oncology Antibody ADC-1013

Alligator Bioscience AB, a privately held Swedish biotech company developing immuno-oncology antibodies for directed immunotherapy of cancer ...

2015-04-272022-09-20

First Patient Dosed by Alligator Bioscience in a Clinical Phase 1 Multicenter Trial in Advanced Solid Tumors with the CD40 Agonistic Immuno- ...

2015-04-072022-09-20

Alligator Bioscience Starts a Clinical Phase 1 Multicenter Trial in Advanced Solid Tumors with the CD40 Agonistic Immuno-Oncology Antibody A ...